BRIEF published on 04/11/2025 at 10:35, 5 days 9 hours ago Eckert & Ziegler Proposes €0.50 Dividend for FY 2024 Annual General Meeting Dividend Eckert & Ziegler Financial Year 2024 TecDax
PRESS RELEASE published on 04/11/2025 at 10:30, 5 days 9 hours ago Eckert & Ziegler Proposes Dividend of € 0.50 for FY 2024 Eckert & Ziegler SE proposes dividend of €0.50 per share for FY 2024. The Annual General Meeting to be held on June 18, 2025 in Berlin Annual General Meeting Shareholders Dividend Eckert & Ziegler SE FY 2024
BRIEF published on 04/10/2025 at 15:05, 6 days 4 hours ago Eckert & Ziegler: US Consul Visits Braunschweig Radiopharmaceutical Facility Cancer Treatment Radiopharmaceuticals Lutetium-177 US Consul Visit Expansion Investment
PRESS RELEASE published on 04/10/2025 at 15:00, 6 days 4 hours ago Eckert & Ziegler: US Consul Visits Radiopharmaceutical Production in Braunschweig US Consul General Jason Chue visits Eckert & Ziegler's radiopharmaceutical production site in Braunschweig, witnessing the production of cancer diagnostics and therapy solutions Eckert & Ziegler Cancer Therapy Radiopharmaceuticals Lutetium-177 Transatlantic Cooperation
BRIEF published on 03/27/2025 at 07:50, 20 days 12 hours ago Eckert & Ziegler Reports Record Year in 2024 Eckert & Ziegler 2024 Financial Results Medical Segment Isotope Products 2025 Forecast
PRESS RELEASE published on 03/27/2025 at 07:45, 20 days 12 hours ago Eckert & Ziegler: Record year 2024 with new all-time highs Eckert & Ziegler SE achieved record sales of €295.8 million in 2024, with significant growth in Medical and Isotope Products segments. Forecasting sales of €320 million and EBIT of €78 million for 2025 Record Sales Eckert & Ziegler SE 2024 Financial Year Medical Segment Isotope Products Segment
BRIEF published on 03/25/2025 at 09:35, 22 days 10 hours ago Eckert & Ziegler to Provide Actinium Pharmaceuticals with Actinium-225 Clinical Trials Acute Myeloid Leukemia Actinium-225 Supply Targeted Radiotherapy Global Shortage
PRESS RELEASE published on 03/25/2025 at 09:30, 22 days 10 hours ago Eckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensive Development Activities Eckert & Ziegler SE to supply Actinium Pharmaceuticals with Ac-225 for comprehensive development activities, targeting cancer treatment with radiotherapies Cancer Treatment Eckert & Ziegler SE Radiotherapy Ac-225 Actinium Pharmaceuticals
BRIEF published on 03/20/2025 at 14:05, 27 days 5 hours ago Eckert & Ziegler Partner with AtomVie on Lutetium-177 Supply Radiopharmaceuticals Lutetium-177 Theralugand Global Agreement AtomVie Partnership
PRESS RELEASE published on 03/20/2025 at 14:00, 27 days 5 hours ago Eckert & Ziegler and AtomVie Global Radiopharma Sign a Global Agreement for Lutetium-177 Supply Eckert & Ziegler SE and AtomVie Global Radiopharma sign a global agreement for Lutetium-177 supply, enhancing radiopharmaceutical development and manufacturing Eckert & Ziegler SE Lutetium-177 Global Agreement AtomVie Global Radiopharma Radiopharmaceutical
Published on 04/16/2025 at 18:45, 1 hour 13 minutes ago New to The Street Renews Acurx Pharmaceuticals (NASDAQ: ACXP) for Exclusive 6-Month Media Series Including Nationwide TV, Earned Media, and Expanded Digital Reach
Published on 04/16/2025 at 15:45, 4 hours 13 minutes ago Organto Foods Closes Private Placement, Debt Settlement and Amendments to Convertible Notes
Published on 04/16/2025 at 15:15, 4 hours 43 minutes ago urban-gro, Inc. Awarded Three New Contracts with Fogo de Chão
Published on 04/16/2025 at 14:30, 5 hours 28 minutes ago LQR House Announces 35-for-1 Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative
Published on 04/16/2025 at 14:30, 5 hours 28 minutes ago enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment
Published on 04/16/2025 at 18:41, 1 hour 16 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/16/2025 at 18:10, 1 hour 48 minutes ago Annual general meeting 2025: all proposals of the board of directors approved and Manja Greimeier elected
Published on 04/16/2025 at 18:00, 1 hour 58 minutes ago Mikron shareholders approve all proposals of the Board of Directors
Published on 04/16/2025 at 17:59, 1 hour 59 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/16/2025 at 18:42, 1 hour 16 minutes ago Deezer unveils new features to offer music fans an even more personalized experience
Published on 04/16/2025 at 17:46, 2 hours 12 minutes ago Covivio - Q1 2025 activity: +5.4% revenue growth year-on-year
